…
China Health Management Corp. operates as a healthcare and management company in China. It focuses on the operation and management of hospitals. The company provides healthcare services in the areas of gynaecology and obstetrics, paediatrics, stomatology, dermatology, medical cosmetology, pathology, ophthalmology and otolaryngology, anesthesia, and haemodialysis. Its services also include surgery, emergency medicine, intensive care, preventive medicine, pharmacy, psychological consultation therapy, medical consultation, combined Chinese and Western medicine, medical examination, medical imaging, medical functions examination, commissioning hospital management, hospital management consultation, etc. The company was formerly known as Max Internet Communications, Inc. and changed its name to China Health Management Corp. in March 2006. China Health Management Corp. was incorporated in 1996 and is based in Dallas, Texas.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
China Health Management Corp (CNHC.US) is an OTC Pink–listed company that describes itself as providing health management and preventive healthcare services in China. Long-term growth drivers could include China’s aging population and rising per-capita healthcare spending, which may benefit firms focused on prevention and chronic-disease management, and investors may find exposure to these secular trends appealing if the company can demonstrate credible operations and transparent reporting.
The most important investment risks are limited and inconsistent public disclosures, thin trading liquidity, weak corporate governance and financial reporting, and regulatory and execution uncertainty that together increase the risk of information asymmetry and potential capital loss.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Income before tax | -0.02M | -0.08M | 0.00M | -0.01M | -0.01M |
| Net income | -0.01M | -0.08M | -0.00M | -0.01M | -0.01M |
| Gross profit | 0.05M | 0.05M | 0.03M | - | - |
| Ebit | 0.01M | -0.04M | -0.22M | -0.25M | -0.22M |
| Ebitda | 0.02M | -0.04M | 0.01M | -0.01M | -0.01M |
| Depreciation and amortization | 0.00M | 0.00M | 0.23M | 0.24M | 0.21M |
| Operating income | 0.01M | -0.04M | 0.01M | -0.01M | -0.01M |
| Other operating expenses | 0.05M | 0.09M | 0.02M | 0.01M | 0.01M |
| Interest expense | 0.04M | 0.04M | 0.01M | - | - |
| Income tax expense | - | -0.00M | 0.00M | -0.24M | -0.21M |
| Total revenue | 0.05M | 0.05M | 0.03M | - | - |
| Total operating expenses | 0.04M | 0.09M | 0.02M | 0.01M | 0.01M |
| Cost of revenue | 0.00M | 0.00M | - | - | - |
| Total other income expense net | -0.03M | -0.04M | -0.01M | 0.00M | -0.00M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Total assets | 0.94M | 1.21M | 1.23M | - | - |
| Total liab | 1.13M | 1.37M | 1.26M | 0.02M | - |
| Total stockholder equity | -0.20M | -0.16M | -0.03M | -0.02M | - |
| Other current liab | 0.66M | 0.71M | 0.54M | 0.00M | - |
| Common stock | 0.08M | 0.08M | 0.08M | 0.08M | - |
| Retained earnings | -27.91M | -27.88M | -27.81M | -27.80M | - |
| Other assets | - | 0.00M | - | - | - |
| Cash | 0.01M | 0.01M | 0.01M | - | - |
| Total current liabilities | 1.13M | 1.37M | 1.26M | 0.02M | - |
| Net debt | 0.45M | 0.65M | 0.71M | 0.02M | - |
| Short term debt | 0.47M | 0.66M | 0.72M | 0.02M | - |
| Short long term debt total | 0.47M | 0.66M | 0.72M | 0.02M | - |
| Other stockholder equity | 27.69M | 27.69M | 27.69M | 27.78M | - |
| Total current assets | 0.01M | 0.02M | 0.01M | - | - |
| Net receivables | 0.00M | 0.00M | 0.00M | - | - |
| Accumulated other comprehensive income | -0.07M | -0.05M | 0.00M | -0.08M | - |
| Non current assets total | 0.93M | 1.20M | 1.21M | - | - |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2020-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2020-06-30 |
| Total cashflows from investing activities | 0.44M | - | 0.01M | - | - |
| Total cash from financing activities | -0.41M | -0.04M | -0.03M | 0.01M | 0.00M |
| Net income | -0.01M | -0.08M | -0.00M | -0.01M | -0.00M |
| Change in cash | -0.00M | 0.00M | 0.01M | - | - |
| Begin period cash flow | 0.01M | 0.01M | -0.00M | - | - |
| End period cash flow | 0.01M | 0.01M | 0.01M | - | - |
| Total cash from operating activities | -0.03M | 0.04M | 0.03M | -0.01M | -0.00M |
| Depreciation | 0.00M | 0.00M | - | - | - |
| Other cashflows from investing activities | - | -0.00M | - | - | - |
| Change to account receivables | -0.00M | -0.00M | -0.00M | - | - |
| Other cashflows from financing activities | - | -0.04M | 0.01M | 0.01M | 0.00M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | -0.05M | 0.08M | 0.03M | 0.00M | - |
| Other non cash items | 0.02M | 0.04M | 0.01M | - | - |
| Free cash flow | -0.03M | 0.04M | 0.03M | -0.01M | -0.00M |
Sector: Real Estate Industry: Real Estate Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CNHC China Health Management Corp |
- -% |
0.00 | - | - | 0.76 | - | 1.26 | -0.05 |
| CBRE CBRE Group Inc Class A |
7.90 6.13% |
136.75 | 38.92 | 21.37 | 1.09 | 4.95 | 1.28 | 25.73 |
| BEKE Ke Holdings Inc |
-0.20 1.14% |
17.70 | 42.90 | 16.92 | 0.33 | 2.33 | 1.66 | 24.07 |
| VNNVF Vonovia SE |
0.83 4.72% |
18.40 | - | 13.44 | 3.96 | 0.83 | 4.07 | -3.05 |
| VTAGY Vantage Towers AG |
- -% |
21.42 | 42.00 | 37.59 | 28.32 | 3.61 | 21.19 | 24.26 |
China Health Management Corp. operates as a healthcare and management company in China. It focuses on the operation and management of hospitals. The company provides healthcare services in the areas of gynaecology and obstetrics, paediatrics, stomatology, dermatology, medical cosmetology, pathology, ophthalmology and otolaryngology, anesthesia, and haemodialysis. Its services also include surgery, emergency medicine, intensive care, preventive medicine, pharmacy, psychological consultation therapy, medical consultation, combined Chinese and Western medicine, medical examination, medical imaging, medical functions examination, commissioning hospital management, hospital management consultation, etc. The company was formerly known as Max Internet Communications, Inc. and changed its name to China Health Management Corp. in March 2006. China Health Management Corp. was incorporated in 1996 and is based in Dallas, Texas.
| Name | Title | Year Born |
|---|---|---|
| Dr. Xu Mei | CEO, Pres & Director | NA |
| Mr. Liang Xu | Head of Fin. & Accounting and Admin. Director | NA |
| Ms. Ni Wang Shu | Head Nurse of Patient Care Services Department | NA |
| Mr. Rui Qu | Department Head of Physical Examination Department | NA |
| Mr. Charles Chen | Chief Medical Officer of Medical Department | NA |
| Dr. Xu Mei | CEO, President & Director | NA |
| Mr. Liang Xu | Head of Finance & Accounting and Administrative Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.